Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to ...

I once believed that healing meant curing—that a good doctor must fight relentlessly against disease, offering every patient ...

In an interview with Targeted Oncology, David J. Benjamin, MD, discussed findings on the global oncology workforce and their ...

The "Fair-Market Value Compensation Rates for Oncology KOLs - Switzerland" report has been added to ResearchAndMarkets.com's offering. KOL FMV Rates Oncology Switzerland presents fair-market value ...

Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...

George Mulligan, PhD, discusses the ODAC's review of daratumumab for high-risk smoldering multiple myeloma, noting its efficacy in delaying progression but raising questions about patient criteria. In ...

Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month. Survivorship can mean something different to ...

Entitled “International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma,” the peer-reviewed article, published online on ...